In a significant move, UK-based pharmaceutical giant GlaxoSmithKline (GSK) has sealed a three-year, £2.5 billion deal with Chongqing Zhifei Biological Products Co., aiming to fortify the presence of its shingles
Gain insights into GSK’s contributions to the medical industry, its innovations, and its impact on global health